Analystreport

Vertex Pharmaceuticals (VRTX) had its price target raised by Truist Financial Corporation from $490.00 to $525.00. They now have a "buy" rating on the stock.

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com